- The angiography devices market encompasses a range of medical imaging equipment and consumables used to visualize blood vessels and organs. This includes angiography systems (C-arms, cath labs), catheters, guide wires, contrast media injectors, and other accessories. These devices are crucial for diagnosing and treating various cardiovascular, neurological, and peripheral vascular diseases. The market is driven by the increasing prevalence of cardiovascular diseases, technological advancements in imaging, and the growing demand for minimally invasive procedures.
- The escalating demand for angiography devices is primarily fueled by the increasing number of interventional cardiology and radiology procedures, the growing adoption of minimally invasive techniques, and the rising awareness of the benefits of early diagnosis and intervention in vascular diseases.
- The U.S. dominates the Angiography Devices market in North America with the largest revenue share of 87.45% in 2025, attributed to its well-established healthcare infrastructure, higher adoption rates of minimally invasive procedures, increased prevalence of cardiovascular diseases, and strong investments in interventional cardiology. The presence of leading manufacturers and high R&D spending further supports the market growth.
- The U.S. is expected to be the fastest-growing country in the North America Angiography Devices market driven by rising geriatric population, favorable reimbursement policies, and growing demand for technologically advanced devices such as flat-panel detectors and 3D rotational angiography systems. Continuous clinical advancements and strategic collaborations among key players are also contributing to market expansion.
- Angiography Catheters is expected to dominate the North America Angiography Devices market with a market share of 38.2% in 2025, owing to its precision in imaging vascular conditions, wide applicability in coronary and peripheral angiography procedures, and increasing adoption in both diagnostic and interventional cardiology due to its minimally invasive nature and clinical efficacy.
